In the intricate world of pharmaceutical manufacturing, understanding the precise role and sourcing requirements of each active pharmaceutical ingredient (API) is crucial for success. Pentoxyverine Citrate (CAS 23142-01-0) is one such compound, playing a significant part in the development of effective antitussive and respiratory medications. This article explores its applications and the manufacturing considerations that pharmaceutical companies must address when incorporating it into their product lines.

Pentoxyverine Citrate is a well-established ingredient known for its efficacy in managing coughs. Its primary function is to suppress the cough reflex, providing relief for patients suffering from coughs associated with common colds, bronchitis, and other respiratory ailments. Its therapeutic benefits also extend to its local anesthetic properties, which can soothe irritated throat tissues. For pharmaceutical formulators, sourcing high-quality Pentoxyverine Citrate is key to ensuring the optimal performance and safety of their end products.

Manufacturing pharmaceutical products that contain Pentoxyverine Citrate requires a meticulous approach to API sourcing. Buyers must prioritize suppliers who can consistently deliver material that meets stringent quality specifications. This includes not only high purity levels (often ≥99%) but also compliance with recognized pharmacopoeia standards such as USP, BP, and EP. Furthermore, manufacturers must ensure that their production processes align with GMP guidelines, guaranteeing batch-to-batch consistency and minimizing the risk of contamination.

The supply chain for pharmaceutical intermediates like Pentoxyverine Citrate is often global. Many pharmaceutical companies choose to source directly from manufacturers in China due to their competitive pricing and large-scale production capabilities. When engaging with these suppliers, it is essential to establish clear communication regarding the entire process, from the initial quote for Pentoxyverine Citrate to the final delivery. This includes obtaining all necessary documentation, such as CoAs, MSDS, and TDS, which are vital for regulatory submissions and quality control within the manufacturing facility.

The application of Pentoxyverine Citrate extends beyond simple cough suppressants. Its properties can be leveraged in a variety of formulations aimed at improving respiratory health. As a pharmaceutical intermediate, its consistent availability and quality are critical for uninterrupted production cycles. Companies looking to purchase Pentoxyverine Citrate should also consider the supplier's ability to provide custom packaging solutions or specific lot sizes to match their manufacturing needs, further optimizing their operational efficiency.

In summary, Pentoxyverine Citrate (CAS 23142-01-0) is a vital API with well-defined applications in the pharmaceutical industry, particularly in the development of cough and respiratory medications. Pharmaceutical manufacturers must place a strong emphasis on sourcing from suppliers who can guarantee high purity, adherence to international quality standards, and reliable manufacturing practices. By carefully managing the procurement of this essential chemical, companies can ensure the quality and market success of their pharmaceutical products.